Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy
Faraday Future (NASDAQ: FFAI) has completed a strategic investment in Qualigen Therapeutics (NASDAQ: QLGN), which is set to rebrand as CXC10. The $41 million investment includes a $30 million contribution from FF, securing approximately 55% ownership of QLGN's pro forma common stock.
FF Founder and Global Co-CEO YT Jia invested $4 million for a 7% stake, with a voluntary two-year lock-up period. Additional investors include SIGN Foundation, backed by notable firms like Binance Labs, Sequoia Capital, IDG, and Circle. This investment, announced during FF's 919 Futurist Day, marks a strategic move to integrate EAI, crypto, Web2, and Web3 technologies as part of FF's Dual-Flywheel & Dual-Bridge Eco-Strategy.
Faraday Future (NASDAQ: FFAI) ha completato un investimento strategico in Qualigen Therapeutics (NASDAQ: QLGN), che si rinominerà CXC10. L'investimento di $41 milioni include un contributo di $30 milioni da FF, assicurando circa il 55% della proprietà delle azioni ordinarie pro forma di QLGN.
Il fondatore di FF e co-CEO globale YT Jia ha investito $4 milioni per una participazione del 7%, con un periodo di lock-up volontario di due anni. Altri investitori includono SIGN Foundation, sostenuta da importanti realtà come Binance Labs, Sequoia Capital, IDG e Circle. Questo investimento, annunciato durante FF's 919 Futurist Day, segna una mossa strategica per integrare EAI, crypto, Web2 e Web3 tecnologie come parte della Dual-Flywheel & Dual-Bridge Eco-Strategy di FF.
Faraday Future (NASDAQ: FFAI) ha completado una inversión estratégica en Qualigen Therapeutics (NASDAQ: QLGN), que se rebautizará como CXC10. La inversión de $41 millones incluye una aportación de $30 millones por parte de FF, asegurando aproximadamente el 55% de la propiedad de las acciones comunes pro forma de QLGN.
El fundador de FF y copresidente mundial YT Jia invirtió $4 millones por una participación del 7%, con un período de bloqueo voluntario de dos años. Otros inversores incluyen SIGN Foundation, respaldada por firmas notables como Binance Labs, Sequoia Capital, IDG y Circle. Esta inversión, anunciada durante el 919 Futurist Day de FF, marca un movimiento estratégico para integrar EAI, cripto, Web2 y Web3 tecnologías como parte de la Dual-Flywheel & Dual-Bridge Eco-Strategy de FF.
Faraday Future (NASDAQ: FFAI)는 Qualigen Therapeutics (NASDAQ: QLGN)에 대한 전략적 투자를 완료했으며, 이 회사는 CXC10으로 브랜드를 바꿀 예정입니다. 4100만 달러의 투자 중 FF의 3000만 달러 기여가 포함되어 QLGN의 프로 포르마 보통주의 약 55% 지분을 확보합니다.
FF의 창립자이자 글로벌 공동 CEO인 YT Jia는 400만 달러를 투자해 7% 지분을 얻었으며, 자발적 2년 잠금 기간이 있습니다. 다른 투자자에는 Binance Labs, Sequoia Capital, IDG, Circle이 지원하는 SIGN Foundation이 포함됩니다. 이 투자는 FF의 919 Futurist Day에서 발표되었으며, FF의 Dual-Flywheel & Dual-Bridge Eco-Strategy의 일부로 EAI, 암호화폐, Web2 및 Web3 기술을 통합하는 전략적 움직임을 나타냅니다.
Faraday Future (NASDAQ: FFAI) a finalisé un investissement stratégique dans Qualigen Therapeutics (NASDAQ: QLGN), qui sera rebaptisée CXC10. L'investissement de 41 millions de dollars comprend une contribution de 30 millions de dollars de FF, assurant environ 55% de propriété des actions ordinaires pro forma de QLGN.
Le fondateur de FF et co-PDG mondial YT Jia a investi 4 millions de dollars pour une participation de 7%, avec une période de lock-up volontaire de deux ans. D'autres investisseurs incluent SIGN Foundation, soutenue par des sociétés notables telles que Binance Labs, Sequoia Capital, IDG et Circle. Cet investissement, annoncé lors du FF's 919 Futurist Day, marque une démarche stratégique pour intégrer l'EAI, la crypto, le Web2 et le Web3 dans le cadre de la Dual-Flywheel & Dual-Bridge Eco-Strategy de FF.
Faraday Future (NASDAQ: FFAI) hat eine strategische Investition in Qualigen Therapeutics (NASDAQ: QLGN) abgeschlossen, das sich in CXC10 umbenennen wird. Die 41 Millionen USD Investition umfasst einen Beitrag von FF in Höhe von 30 Millionen USD und sichert ca. 55% Eigentum an den pro forma Stammaktien von QLGN.
FF-Gründer und Global Co-CEO YT Jia hat 4 Millionen USD für eine 7%-Beteiligung investiert, mit einer freiwilligen Sperrfrist von zwei Jahren. Weitere Investoren beinhalten SIGN Foundation, unterstützt von renommierten Firmen wie Binance Labs, Sequoia Capital, IDG und Circle. Diese Investition, bekanntgegeben während FFs 919 Futurist Day, markiert eine strategische Bewegung, EAI, Krypto, Web2 und Web3 Technologien als Teil der Dual-Flywheel & Dual-Bridge Eco-Strategy von FF zu integrieren.
فاردَيْ فِيُوتشر (ناسداك: FFAI) أكملت استثماراً استراتيجياً في Qualigen Therapeutics (ناسداك: QLGN)، التي ستعيد تسمية علامتها إلى CXC10. الاستثمار البالغ 41 مليون دولار يتضمن مساهمة من FF بقيمة 30 مليون دولار، مما يضمن ملكية تقارب 55% من أسهم QLGN العادية وفقاً للوضع المؤقت.
استثمر مؤسس FF والرئيس التنفيذي العالمي المشارك YT Jia 4 ملايين دولار مقابل حصة قدرها 7%، مع فترة قفل طوعي تبلغ سنتين. من بين المستثمرين الآخرين SIGN Foundation، المدعومة من شركات بارزة مثل Binance Labs وSequoia Capital وIDG وCircle. هذا الاستثمار، الذي أُعلن خلال يوم Futurist 919 الخاص بـ FF، يمثل خطوة استراتيجية لدمج EAI والعملات المشفرة وWeb2 وWeb3 ضمن إستراتيجية Eco-Strategy ذات الدوار المزدوج لدى FF.
Faraday Future (纳斯达克股票代码：FFAI) 已完成对 Qualigen Therapeutics (纳斯达克股票代码：QLGN) 的战略投资，该公司将改名为 CXC10。4100万美元的投资中，FF 贡献了< b>3000万美元，确保 QLGN 的前瞻性普通股约< b>55%的所有权。
FF 创始人兼全球联合首席执行官 YT Jia 投资 400万美元，持有 7% 的股份，另有两年自愿锁定期。其他投资者包括 SIGN Foundation，由 Binance Labs、Sequoia Capital、IDG 与 Circle 等知名机构支持。此项投资在 FF 的 919 Futurist Day 发布，标志着 FF 将 EAI、加密货币、Web2 与 Web3 技术整合入其 Dual-Flywheel & Dual-Bridge Eco-Strategy 的战略举措。
- None.
- Significant capital allocation away from core EV business
- Risk exposure to volatile crypto and Web3 markets
- Potential deviation from traditional automotive business model
QLGN is expected to rebrand as CXC10 soon, reflecting its new strategic direction around crypto and web3 business.
LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced the successful closing of its announced strategic investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a public company establishing new crypto and Web3-related adventures.
The total investment amounts to approximately
With the closing, FF now holds approximately
The strategic investment was first announced during FF’s annual 919 Futurist Day on September 19, 2025, and represents a critical milestone in executing FF’s “Dual-Flywheel & Dual-Bridge” Eco-Strategy.
“With this investment officially closed, Faraday Future is entering a new phase in executing its global eco-strategy that links EAI and crypto, Web2 and Web3,” said YT Jia, Founder and Global Co-CEO of Faraday Future. “This powerful ecosystem will create new value for both stockholders and token holders across FF and CXC10.”
ABOUT FARADAY FUTURE
Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company’s mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future’s flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit https://www.ff.com/us/
FORWARD LOOKING STATEMENTS
This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “plan to,” “can,” “will,” “should,” “future,” “potential,” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding the Company’s intentions for its crypto assets and subsidiaries and their potential benefits, Involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, which could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important factors, among others, that may affect actual results or outcomes include, among others: the separate listed entity’s ability to raise future capital on attractive terms, if at all; the Company’s ability to control the management and operations of the separate listed entity; the Company’s ability to successfully execute on a new Crypto-based strategy; the Company’s ability to raise funds to support a new Crypto-based strategy; the inherent volatility and regulatory uncertainty associated with cryptocurrency investments; current and potential litigation involving the Company; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to cover future warranty claims; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-K filed with the SEC on March 31, 2025, and other documents filed by the Company from time to time with the SEC.
CONTACTS:
Investors (English): ir@faradayfuture.com
Investors (Chinese): cn-ir@faradayfuture.com
Media: john.schilling@ff.com
FAQ
What is the total value of Faraday Future's investment in Qualigen Therapeutics (QLGN)?
How much ownership stake did Faraday Future (FFAI) acquire in QLGN?
What is YT Jia's investment and commitment in the QLGN deal?
Who are the other investors participating in the QLGN investment with Faraday Future?
What is the strategic purpose of Faraday Future's investment in QLGN?
